Traditional Chinese medicine prescription for treating lung cancer and preparation method thereof

Abstract

The present invention relates to a traditional Chinese medicine prescription for treating lung cancer and a preparation method thereof, aims to solve problems that in the prior art, medicines for treating the lung cancer are high in price and poor in therapeutic effects. A provided technical scheme is as follows: the traditional Chinese medicine prescription for treating the lung cancer comprisesthe following components in parts by weight: 28-32 parts of shuanglongcao (solidago decurrens), 28-32 parts of angelica decursiva, 18-22 parts of dried radix rehmanniae, 10-14 parts of radix asparagi,18-22 parts of herba houttuyniae, 10-14 parts of cortex moutan and 10-14 parts of alkanet roots. The preparation method comprises the following steps: S1, prescribed amounts of medicinal materials are weighed and the medicinal materials are successively put into an earthen pot; S2, clean water is added into the earthen pot for boiling for 1 hour; and filtering is conducted to collect a filter residue and a filtrate; S3, clean water is further added into the filter residue for boiling for 1 hour; and filtering is conducted to collect a filtrate; and S4, the filtrates obtained after the twice filtering are combined to obtain the traditional Chinese medicine prescription. The traditional Chinese medicine prescription is simple in compositions, inexpensive and relatively good healing effects.

Description

technical field [0001] The invention relates to a traditional Chinese medicine prescription and a preparation method thereof, in particular to a traditional Chinese medicine prescription for treating lung cancer and a preparation method thereof. Background technique [0002] According to the statistics of the World Health Organization, the annual incidence of cancer in the world is about 10 million, and about 7 million people die of cancer. It has become the second killer of human beings after cardiovascular disease. The mortality rate of lung cancer is the first among cancers. Clinically, lung cancer can be divided into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Among them, NSCLC includes adenocarcinoma, squamous cell carcinoma and large cell lung cancer, accounting for about 80% of the total number of lung cancers. -85%. Due to the lack of early diagnosis and effective treatment, the 5-year survival rate of NSCLC is less than 15%. Although chemo...

AI Technical Summary

Problems solved by technology

There are many kinds of medicines for the treatment of lung cancer at present, but the cure rate is not high, and there are disadvantages that the price of medicines is relatively high, and patients need to take medicines for a long time

[0004] For example, the publication date is July 21, 2004, and the Chinese patent with the publication number CN1158091C proposes a Chinese medicine composition for the treatment of lung cancer. Drugs such as Cordyceps sinensis and Radix Arrhea used in this invention are relatively expensive, and the Chinese medicine composition needs long-term Take it to be effective